Cargando…

Attitudes and behaviour regarding dose reduction of biologics for psoriasis: a survey among dermatologists worldwide

Dose reduction (DR) of biologics, where possible, seems promising for more efficient use of expensive biologics. For implementation of DR strategies, it is essential to get insight in factors that influence implementation. The objective of this study was to evaluate the attitudes and behaviour regar...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Muijen, M. E., van der Schoot, L. S., van den Reek, J. M. P. A., de Jong, E. M. G. J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307528/ https://www.ncbi.nlm.nih.gov/pubmed/34467442 http://dx.doi.org/10.1007/s00403-021-02273-4

Ejemplares similares

Dose Tapering of Biologics in Patients with Psoriasis: A Scoping Review
por: Michielsens, C. A. J., et al.
Publicado: (2021)

Regaining adequate treatment responses in patients with psoriasis who discontinued dose reduction of adalimumab, etanercept or ustekinumab
por: van der Schoot, Lara S., et al.
Publicado: (2022)

Patients’ perspectives towards biologic dose reduction in psoriasis: a qualitative study
por: van der Schoot, L. S., et al.
Publicado: (2023)

Evaluation of a One-step Dose Reduction Strategy of Adalimumab, Etanercept and Ustekinumab in Patients with Psoriasis in Daily Practice
por: ATALAY, Selma, et al.
Publicado: (2021)

Steps towards implementation of protocolized dose reduction of adalimumab, etanercept and ustekinumab for psoriasis in daily practice
por: van der Schoot, L.S., et al.
Publicado: (2023)

Considerable variation among Iranian dermatologists in the knowledge and attitudes regarding the use of biologic agents to manage psoriasis(,)()
por: Almasi-Nasrabadi, Mina, et al.
Publicado: (2019)

Data‐driven prediction of biologic treatment responses in psoriasis: steps towards precision medicine
por: van der Schoot, L. S., et al.
Publicado: (2021)

Unmet Personal Patient Needs in Psoriasis Patients with Low Disease Activity on Adalimumab, Etanercept or Ustekinumab
por: van Muijen, Marloes E., et al.
Publicado: (2021)

Dose reduction of the new generation biologics (IL-17 and IL-23 inhibitors) in psoriasis: study protocol for an international, pragmatic, multicenter, randomized, controlled, non-inferiority study—the BeNeBio study
por: van der Schoot, Lara S., et al.
Publicado: (2021)

The Skin May Clear But the Arthritis Won’t Disappear: Focusing on Concomitant and New-Onset Psoriatic Arthritis in a Daily Practice Cohort of Psoriasis Patients on Biologic Therapy
por: van Muijen, Marloes E, et al.
Publicado: (2020)

Tight controlled dose reduction of biologics in psoriasis patients with low disease activity: a randomized pragmatic non-inferiority trial
por: Atalay, Selma, et al.
Publicado: (2017)

Attitudes among dermatologists regarding actinic keratosis treatment options
por: Moretta, Gaia, et al.
Publicado: (2022)

Real-world Data Reveal Long Drug Survival for Guselkumab in Patients with Plaque Psoriasis
por: VAN MUIJEN, Marloes E., et al.
Publicado: (2022)

Dermatologists’ attitude towards psoriasis treatment during the COVID-19 pandemic
por: Torres, Tiago, et al.
Publicado: (2021)

Predicting treatment success with biologics in psoriasis
por: van den Reek, J.M.P.A.
Publicado: (2019)

Attitudes among dermatologists regarding non-melanoma skin cancer treatment options
por: Fania, Luca, et al.
Publicado: (2021)

Alcohol and Psoriasis for the Dermatologist: Know, Screen, Intervene
por: Kearney, Niamh, et al.
Publicado: (2022)

A study of attitudes among Polish dermatologists and dermatology trainees regarding modern technologies in medicine
por: Patrzyk, Sebastian, et al.
Publicado: (2022)

Attitudes towards using electronic health records of patients with psoriasis and dermatologists: a cross-sectional study
por: Klein, Toni Maria, et al.
Publicado: (2020)

Health Economic Consequences of a Tightly Controlled Dose Reduction Strategy for Adalimumab, Etanercept and Ustekinumab Compared with Standard Psoriasis Care: A Cost-utility Analysis of the CONDOR Study
por: ATALAY, Selma, et al.
Publicado: (2020)

Dermatologist and Patient Preferences in Choosing Treatments for Moderate to Severe Psoriasis
por: Alcusky, Matthew, et al.
Publicado: (2017)

Vitamin D and its role in psoriasis: An overview of the dermatologist and nutritionist
por: Barrea, Luigi, et al.
Publicado: (2017)

What Dermatologists Do Not Know about Smallpox Vaccination: Results from a Worldwide Electronic Survey
por: Dellavalle, Robert P., et al.
Publicado: (2006)

Attitudes of dermatologists in the southeastern United States regarding treatment of alopecia areata: a cross-sectional survey study
por: Mukherjee, Niyati, et al.
Publicado: (2009)

The Effect of Lifestyle Changes on Disease Severity and Quality of Life in Patients with Plaque Psoriasis: A Narrative Review
por: van Acht, Maartje R, et al.
Publicado: (2022)

Gaps in moderate plaque psoriasis management: A survey of Saudi dermatologists
por: Almohideb, Mohammad, et al.
Publicado: (2021)

A Survey of Treatment Practices in Management of Psoriasis Patients among Dermatologists of Kerala
por: Nazeer, Mohammed, et al.
Publicado: (2019)

Living with Psoriasis Vulgaris and Multi-Treatment Failure: A Patient and Dermatologist Perspective
por: Spencer, Riley K., et al.
Publicado: (2023)

Direct Comparison of Real-world Effectiveness of Biologics for Psoriasis using Absolute and Relative Psoriasis Area and Severity Index Scores in a Prospective Multicentre Cohort
por: VAN MUIJEN, Marloes. E., et al.
Publicado: (2022)

Clinical, laboratory, and genetic markers for the development or presence of psoriatic arthritis in psoriasis patients: a systematic review
por: Mulder, Michelle L. M., et al.
Publicado: (2021)

COVID-19 and the Dermatologist
por: FREEMAN, ESTHER E., et al.
Publicado: (2021)

Discovery of Psoriatic Arthritis in Psoriasis Patients for Early Rheumatological Referral (DAPPER) Study: A Prospective Observational Cohort
por: VAN HAL, Tamara W., et al.
Publicado: (2022)

A dermatologist guide to immunogenicity()()
por: Blattner, Collin M., et al.
Publicado: (2016)

A Study of Awareness and Screening Behavior of Cardiovascular Risk Factors in Patients with Psoriasis and Dermatologists
por: Lee, Min Kyung, et al.
Publicado: (2015)

Therapeutic Inertia in the Management of Psoriasis: A Quantitative Survey Among Indian Dermatologists and Patients
por: Rajagopalan, Murlidhar, et al.
Publicado: (2022)

Psychosexual disorders and dermatologists
por: Narang, Tarun, et al.
Publicado: (2016)

Metformin - For the dermatologist
por: Bubna, Aditya Kumar
Publicado: (2016)

Web-based study on Chinese dermatologists’ attitudes towards artificial intelligence
por: Shen, Changbing, et al.
Publicado: (2020)

Dermatologists’ Knowledge and Attitude Toward Isotretinoin Ocular Side Effects in Egypt
por: Elshafie, Mohammed, et al.
Publicado: (2021)

Attitudes Towards Artificial Intelligence Among Dermatologists Working in Saudi Arabia
por: Al-Ali, Fatima, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6l2jlc2jgiv5j6idfh2n4dean3